CMN 571 Final Exam – 2026/2027 Edition –
300 Complete Questions & Correct
Answers
Questions with Step-by-Step Answers | 100% Verified | A+ Graded Review
OVERVIEW:
CMN 571 Final Exam – 2026/2027 covers advanced pharmacology integrating
pathophysiology, pharmacotherapeutics, and evidence-based prescribing across
lifespan. Topics include cardiovascular, hypertension, heart failure, dyslipidemia,
anticoagulation, respiratory, asthma, COPD, endocrine, diabetes, thyroid,
infectious disease, antibiotics, CNS, depression, anxiety, seizures, pain, opioids,
substance use, gastrointestinal, renal, geriatric, pregnancy, lactation, drug
interactions, adverse effects, pharmacogenomics, monitoring, patient education,
and safe, guideline-driven clinical decision-making for primary care emphasizing
ethical considerations, health equity, and clinical competence for diverse
populations ensuring readiness for advanced practice roles.
Answers are in bold Green, with rationales after.
1. Q1: A 68yo with AFib on warfarin has INR 4.5 without bleeding. Appropriate action
is:
A. Give FFP
B. Hold warfarin, consider low-dose oral vitamin K ✓ CORRECT
C. Increase warfarin
D. Give vitamin K IV 10mg
Rationale: INR 4.5-10 without bleeding: hold warfarin, consider low-dose vitamin K
2.5mg PO, recheck.
,2. Q2: Which statin requires dose adjustment in severe renal impairment?
A. All require adjustment
B. Pravastatin
C. Atorvastatin
D. Rosuvastatin ✓ CORRECT
Rationale: Rosuvastatin requires dose reduction in severe renal impairment;
atorvastatin does not.
3. Q3: SSRI with longest half-life increasing risk of drug interactions:
A. Fluoxetine ✓ CORRECT
B. Paroxetine
C. Escitalopram
D. Sertraline
Rationale: Fluoxetine half-life 4-6 days, metabolite norfluoxetine 7-15 days, highest
interaction risk.
4. Q4: First-line for acute uncomplicated cystitis in non-pregnant woman:
A. Nitrofurantoin 100mg BID x5 days ✓ CORRECT
B. Amoxicillin
C. Ciprofloxacin
D. Azithromycin
Rationale: IDSA recommends nitrofurantoin x5d or TMP-SMX or fosfomycin for
uncomplicated cystitis.
,5. Q5: Sign of beta-blocker toxicity:
A. Hypertension
B. Bradycardia and hypoglycemia masking ✓ CORRECT
C. Hyperglycemia
D. Tachycardia
Rationale: Beta-blockers cause bradycardia, hypotension, mask hypoglycemia, may
cause bronchospasm.
6. Q6: ACE inhibitor teratogenicity risk is highest in:
A. Second and third trimester ✓ CORRECT
B. Only during lactation
C. No risk
D. First trimester
Rationale: ACE/ARBs cause fetal renal dysplasia, oligohydramnios in 2nd/3rd
trimester; contraindicated.
7. Q7: Drug causing orange discoloration of body fluids:
A. Vancomycin
B. Rifampin ✓ CORRECT
C. Metronidazole
D. Ethambutol
Rationale: Rifampin causes red-orange discoloration of urine, sweat, tears.
8. Q8: Antidote for benzodiazepine overdose:
A. Flumazenil ✓ CORRECT
, B. Physostigmine
C. Naloxone
D. Protamine
Rationale: Flumazenil is competitive benzodiazepine antagonist.
9. Q9: Warfarin interacts with TMP-SMX leading to:
A. Decreased INR
B. No effect
C. Increased INR and bleeding ✓ CORRECT
D. Decreased warfarin absorption
Rationale: TMP-SMX inhibits CYP2C9, increases warfarin levels and INR.
10. Q10: First-line for mild persistent asthma:
A. SABA daily
B. Oral steroids
C. LABA alone
D. Low-dose ICS ✓ CORRECT
Rationale: Low-dose ICS is preferred controller for mild persistent asthma per
GINA/NAEPP.
11. Q11: A 68yo with AFib on warfarin has INR 4.5 without bleeding. Appropriate
action is:
A. Give FFP
B. Hold warfarin, consider low-dose oral vitamin K ✓ CORRECT
C. Increase warfarin
300 Complete Questions & Correct
Answers
Questions with Step-by-Step Answers | 100% Verified | A+ Graded Review
OVERVIEW:
CMN 571 Final Exam – 2026/2027 covers advanced pharmacology integrating
pathophysiology, pharmacotherapeutics, and evidence-based prescribing across
lifespan. Topics include cardiovascular, hypertension, heart failure, dyslipidemia,
anticoagulation, respiratory, asthma, COPD, endocrine, diabetes, thyroid,
infectious disease, antibiotics, CNS, depression, anxiety, seizures, pain, opioids,
substance use, gastrointestinal, renal, geriatric, pregnancy, lactation, drug
interactions, adverse effects, pharmacogenomics, monitoring, patient education,
and safe, guideline-driven clinical decision-making for primary care emphasizing
ethical considerations, health equity, and clinical competence for diverse
populations ensuring readiness for advanced practice roles.
Answers are in bold Green, with rationales after.
1. Q1: A 68yo with AFib on warfarin has INR 4.5 without bleeding. Appropriate action
is:
A. Give FFP
B. Hold warfarin, consider low-dose oral vitamin K ✓ CORRECT
C. Increase warfarin
D. Give vitamin K IV 10mg
Rationale: INR 4.5-10 without bleeding: hold warfarin, consider low-dose vitamin K
2.5mg PO, recheck.
,2. Q2: Which statin requires dose adjustment in severe renal impairment?
A. All require adjustment
B. Pravastatin
C. Atorvastatin
D. Rosuvastatin ✓ CORRECT
Rationale: Rosuvastatin requires dose reduction in severe renal impairment;
atorvastatin does not.
3. Q3: SSRI with longest half-life increasing risk of drug interactions:
A. Fluoxetine ✓ CORRECT
B. Paroxetine
C. Escitalopram
D. Sertraline
Rationale: Fluoxetine half-life 4-6 days, metabolite norfluoxetine 7-15 days, highest
interaction risk.
4. Q4: First-line for acute uncomplicated cystitis in non-pregnant woman:
A. Nitrofurantoin 100mg BID x5 days ✓ CORRECT
B. Amoxicillin
C. Ciprofloxacin
D. Azithromycin
Rationale: IDSA recommends nitrofurantoin x5d or TMP-SMX or fosfomycin for
uncomplicated cystitis.
,5. Q5: Sign of beta-blocker toxicity:
A. Hypertension
B. Bradycardia and hypoglycemia masking ✓ CORRECT
C. Hyperglycemia
D. Tachycardia
Rationale: Beta-blockers cause bradycardia, hypotension, mask hypoglycemia, may
cause bronchospasm.
6. Q6: ACE inhibitor teratogenicity risk is highest in:
A. Second and third trimester ✓ CORRECT
B. Only during lactation
C. No risk
D. First trimester
Rationale: ACE/ARBs cause fetal renal dysplasia, oligohydramnios in 2nd/3rd
trimester; contraindicated.
7. Q7: Drug causing orange discoloration of body fluids:
A. Vancomycin
B. Rifampin ✓ CORRECT
C. Metronidazole
D. Ethambutol
Rationale: Rifampin causes red-orange discoloration of urine, sweat, tears.
8. Q8: Antidote for benzodiazepine overdose:
A. Flumazenil ✓ CORRECT
, B. Physostigmine
C. Naloxone
D. Protamine
Rationale: Flumazenil is competitive benzodiazepine antagonist.
9. Q9: Warfarin interacts with TMP-SMX leading to:
A. Decreased INR
B. No effect
C. Increased INR and bleeding ✓ CORRECT
D. Decreased warfarin absorption
Rationale: TMP-SMX inhibits CYP2C9, increases warfarin levels and INR.
10. Q10: First-line for mild persistent asthma:
A. SABA daily
B. Oral steroids
C. LABA alone
D. Low-dose ICS ✓ CORRECT
Rationale: Low-dose ICS is preferred controller for mild persistent asthma per
GINA/NAEPP.
11. Q11: A 68yo with AFib on warfarin has INR 4.5 without bleeding. Appropriate
action is:
A. Give FFP
B. Hold warfarin, consider low-dose oral vitamin K ✓ CORRECT
C. Increase warfarin
